Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from SmartBrief

21:15 EST 10th December 2018 | BioPortfolio

Here are the most relevant search results for "SmartBrief" found in our extensive news archives from over 250 global news sources.

More Information about SmartBrief on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about SmartBrief for you to read. Along with our medical data and news we also list SmartBrief Clinical Trials, which are updated daily. BioPortfolio also has a large database of SmartBrief Companies for you to search.

Showing News Articles 1–25 of 3,600+ from SmartBrief

Monday 10th December 2018

An injury is much sooner forgotten than an insult.

Philip Stanhope, statesman and diplomat

India OKs Meril Life Sciences' MyVal TAVR

Meril Life Sciences' MyVal transcatheter aortic heart valve replacement has been launched in India.  -More- 

Contego Medical's peripheral balloon wins FDA clearance

The FDA has granted Contego Medical 510(k) clearance for its Vanguard IEP peripheral balloon, which comes with an embolic pro -More- 

India still lacks comprehensive regulations for medical devices

Indian medtech companies have been waiting for 13 years for health authorities to comply with an order to create a comprehens -More- 

Globus Medical's ExcelsiusGPS debuts in global market

Globus Medical has launched its ExcelsiusGPS robotic guidance and navigation system globally following installations across E -More- 

NIH division awards Bruin Biometrics $1.4M SBIR grant

The NIH's National Institute of Arthritis and Musculoskeletal and Skin Diseases division has awarded Bruin Biometrics a Small -More- 

Report predicts growth for global sports medicine devices market

An Insight Partners report forecasts the worldwide market for sports medicine devices will exceed $10.5 million by 2025, with -More- 

Moody's report gives positive 2019 outlook for US medtech industry

A report from Moody's Investors Service shows a positive outlook in 2019 for the US medical device industry, predicting a 4.5 -More- 

OrthoPediatrics prices common stock offering

An underwritten follow-on common stock offering has been priced by OrthoPediatrics at $27 per share.  -More- 

Inspire Medical Systems announces pricing of stock offering

An offering of 2.5 million shares of common stock has been priced by Inspire Medical Systems at $40 per share.  -More- 

Rights offering pulls in $45M for Pulse Biosciences

An oversubscribed rights offering has brought in $45 million for Pulse Biosciences.  -More- 

BIO One-on-One Partnering™ during JPM Week

BIO is pleased to offer complimentary access to BIO One-on-One Partnering and discounted meeting space to make it easier and  -More- 

Biofuel could help Maersk comply with net zero CO2 target

Maersk sees the use of carbon-neutral fuels such as biofuels as the only possible way to achieve net zero carbon dioxide emis -More- 

Nobel Prize winners: Rules on biotech crops should be loosened

Nobel Prize in chemistry winners professor Frances Arnold and Sir Gregory Winter argued that biotech crops, such as drought a -More- 

Gilead Sciences names Roche exec Daniel O'Day as new CEO

Industry veteran and Roche Holding executive Daniel O'Day has been named the new CEO of Gilead Sciences, replacing John Milli -More- 

Mallinckrodt seeks way to divest generic opioids unit

Mallinckrodt is continuing the search for a buyer for its specialty generics unit, which primarily makes opioids, and will sp -More- 

IPO raises record $604.3M for biotech startup Moderna

In the biggest biotech initial public offering ever to make it to Wall Street, Moderna raised $604.3 million.  -More- 

House to consider bill targeting misclassification of drugs

House lawmakers are expected to vote this week on bipartisan legislation that would permit the federal government to penalize -More- 

Canada approves Adynovate for patients under 12

Shire Pharma Canada's Adynovate, or antihemophilic factor (recombinant), PEGylated, a treatment for hemophilia A patients you -More- 

ASH presentations focus on rare lymphoma types

Three posters covering rare types of lymphoma were presented at the annual meeting of the American Society of Hematology.  -More- 

FDA extends patent for Navidea's Lymphoseek

The FDA has allowed a five-year patent claim extension for Navidea Biopharmaceuticals' Lymphoseek, or technetium (Tc 99m) til -More- 

FDA updates label for Novo Nordisk's Novoeight

Novo Nordisk's Novoeight has been approved by the FDA for control of bleeding episodes and for use as an on-demand therapy in -More- 

Friday 7th December 2018

It is never too late to reform, as long as you have the sense to desire it, and the strength to execute your purpose.

Anne Bronte, writer

FDA OKs Olympus' valve system for severe emphysema

The FDA has granted Olympus approval for its Spiration Valve System for severe emphysema.  -More- 

FDA unveils draft guidance for cancer companion diagnostics

Draft guidance is available from the FDA that aims to facilitate approval of cancer companion diagnostics for a class of drug -More- 


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks